Innovative Med Concepts (IMC) is a biotech company with a pipeline of novel treatments for fibromyalgia and other related conditions that appear to share a common underlying pathophysiology—irritable bowel syndrome (IBS), myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), chronic neck and back pain, and cognitive impairment.

from http://www.innovativemedconcepts.com/index.html

Publications show all

Innovative Med Concepts has published 1 articles.

Patents show all

12Applications7Issued

Clinical Trials show all

1Phase 2

SEC Filings show all

D4

Private Funding Events

DateOfferedSoldType
2015-03-31$6,000,000$0Equity
2013-12-10Indefinite$3,085,000Equity
2013-09-25Indefinite$2,690,000Equity
2012-05-16$3,395,778$610,000Equity

Key Executives

  • William L Pridgen, M.D.
    Executive Officer, Promoter
  • William L Pridgen
    Executive Officer, Director, Promoter
  • Richard A Burch
    Executive Officer, Promoter